Paclitaxel Plus Radiation Therapy in Treating Women With Stage II or Stage III Breast Cancer
Status:
Active, not recruiting
Trial end date:
2022-02-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells.
Combining paclitaxel with radiation therapy may kill more tumor cells.
PURPOSE: This trial is to study the effectiveness of concurrent administration of
chemotherapy and radiation therapy in treating women who have stage II or stage III breast
cancer by examining the complications and cosmetic effects.